According to Zen Score, the 3 best medical distribution stocks to buy right now are:
1. Amerisourcebergen (NYSE:ABC)
Amerisourcebergen (NYSE:ABC) is the top medical distribution stock with a Zen Score of 51, which is 12 points higher than the medical distribution industry average of 39. It passed 19 out of 38 due diligence checks and has strong fundamentals. Amerisourcebergen has seen its stock return 2.49% over the past year, underperforming other medical distribution stocks by -1 percentage points.
Amerisourcebergen has an average 1 year
price target of $180.17, an upside of 15.19% from Amerisourcebergen's current stock price of $156.41.
Amerisourcebergen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Amerisourcebergen, 41.67% have issued a Strong Buy rating, 41.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Patterson Companies (NASDAQ:PDCO)
Patterson Companies (NASDAQ:PDCO) is the second best medical distribution stock with a Zen Score of 46, which is 7 points higher than the medical distribution industry average of 39. It passed 16 out of 38 due diligence checks and has strong fundamentals. Patterson Companies has seen its stock lose -15.33% over the past year, underperforming other medical distribution stocks by -19 percentage points.
Patterson Companies has an average 1 year
price target of $36.40, an upside of 37.05% from Patterson Companies's current stock price of $26.56.
Patterson Companies stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Patterson Companies, 20% have issued a Strong Buy rating, 40% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Henry Schein (NASDAQ:HSIC)
Henry Schein (NASDAQ:HSIC) is the third best medical distribution stock with a Zen Score of 44, which is 5 points higher than the medical distribution industry average of 39. It passed 14 out of 33 due diligence checks and has strong fundamentals. Henry Schein has seen its stock lose -9.92% over the past year, underperforming other medical distribution stocks by -13 percentage points.
Henry Schein has an average 1 year
price target of $86.25, an upside of 8.94% from Henry Schein's current stock price of $79.17.
Henry Schein stock has a consensus Hold recommendation according to Wall Street analysts. Of the 8 analysts covering Henry Schein, 12.5% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 12.5% have issued a Strong Sell.